Promethazine and Vesicare drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Promethazine (promethazine hydrochloride) and Vesicare (solifenacin succinate). Common drug interactions include rash among females and chronic kidney disease among males.
The phase IV clinical study analyzes what interactions people have when they take Promethazine and Vesicare. It is created by eHealthMe based on reports of 265 people who take the same drugs from the FDA, and is updated regularly.
What is Promethazine?
Promethazine has active ingredients of promethazine hydrochloride. It is often used in nausea. eHealthMe is studying from 32,300 Promethazine users. Check the latest studies of Promethazine.
What is Vesicare?
Vesicare has active ingredients of solifenacin succinate. It is often used in urge incontinence. eHealthMe is studying from 30,655 Vesicare users. Check the latest studies of Vesicare.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
265 people who take Promethazine and Vesicare together, and have interactions are studied.
What are the common drug interactions of Promethazine and Vesicare, by gender? *
What are the common drug interactions of Promethazine and Vesicare, by age (0-1 to 60+)? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Promethazine and Vesicare?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Promethazine (32,300 reports)
- Vesicare (30,655 reports)
Browse all drug interactions of Promethazine and Vesicare:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Promethazine:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Vesicare:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Promethazine and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Vesicare and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Teimoory M, Arefi M, Behnoush B, Bastani B, "Promethazine and Treatment Refractory Agitation in Clonidine Toxicity", International Journal of Medical Toxicology and Forensic Medicine, 2013 Mar .
- Teimoory M, Arefi M, Behnoush B, Bastani B, "Promethazine and Treatment Refractory Agitation in Clonidine Toxicity", International Journal of Medical Toxicology and Forensic Medicine, 2013 Mar .
How the study uses the data?
The study uses data from the FDA. It is based on promethazine hydrochloride and solifenacin succinate (the active ingredients of Promethazine and Vesicare, respectively), and Promethazine and Vesicare (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Pramipexole Dihydrochloride vs. Requip, side effect and effectiveness comparison - now
- Could Escitalopram cause Convulsion? - a second ago
- Colorectal Cancer Metastatic and Febrile Neutropenia - a second ago
- Could Gemfibrozil cause Blood Bilirubin Increased? - 2 seconds ago
- Drug interactions of Ondansetron and Calcium Carbonate - 3 seconds ago
- Could Ibuprofen cause Trigger Finger? - 7 seconds ago
- Weight Abnormal in Remeron, how severe and when it was recovered? - 9 seconds ago
- Could Promethazine cause Thrombosis? - 10 seconds ago
- Could Arimidex cause Diarrhea? - 12 seconds ago
- Could Colchicine cause Wound? - 12 seconds ago